Advertisement
News
Subscribe to MDT Magazine News

Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Gentiva Health Services, Inc. to Inquire About the Lead Plaintiff Position in Securities ...

November 19, 2010 10:45 am | by The Associated Press | Comments

Brower Piven, A Professional Corporation announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of purchasers of the common stock of Gentiva Health Services, Inc. ("Gentiva" or the "Company") (NASDAQ: GTIV)...

National Marrow Donor Program® to Speed Transplants with IBM Analytics Software

November 19, 2010 10:37 am | by IBM | Comments

IBM announced today that the National Marrow Donor Program® (NMDP) has adopted IBM's WebSphere Lombardi Business Process Management (BPM) software to help automate its donor and patient management process. Both processes are critical to facilitate the matching of donors to patients...

What?s the buzz on MEMS in 2011 and beyond?

November 19, 2010 10:37 am | by I-Micronews | Comments

MEMS Supply Chain Execs Get OEM Perspective at MEMS Executive Congress 2010.

Advertisement

Lilliputian Systems announces wafer manufacturing supply agreement with Intel and equity stake by Intel Capital

November 19, 2010 10:37 am | by I-Micronews | Comments

Lilliputian Systems, Inc. (www.lilliputiansystems.com), developer of the world?s first Personal Power? solution for consumer electronics devices, today announced that it has signed a Wafer Manufacturing Supply Agreement with Intel.

Two Obagi shareholders selling off their stakes

November 19, 2010 9:45 am | by The Associated Press | Comments

Obagi Medical Products Inc., which makes prescription-strength and over-the-counter skin creams, said Friday that two shareholders are planning to sell off their stakes through a $28.2 million public offering and $35 million buyback agreement with the company.The Stonington Capital Appreciation...

TSX-listed corporate dividends and distributions declared Nov. 19, 2010

November 19, 2010 9:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on Nov. 19, 2010.Daylight Energy Ltd. (TSX:DAY): $0.05. Payable Nov 15. Record Oct 29.Altus Group Income Fund Units (TSX:AIF.UN): $0.1. Payable Dec 15. Record Nov 30.Bell Aliant...

AVEO releases data on cancer drugs

November 19, 2010 9:36 am | by Mass High Tech: The Journal of New England Technology | Comments

AVEO Pharmaceuticals has presented results on a pair of cancer treatments at the Symposium of the European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research in Berlin, Germany.

TOPICS:

Containers to Clinics opens pilot facility in Haiti

November 19, 2010 9:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Containers to Clinics Inc., a Dover startup focused on converting shipping containers to health care clinics, has opened a pilot site in Haiti, associated with Port-au-Prince-based Grace Children’s Hospital, which was about 80 percent destroyed in the January earthquake.

Advertisement

Okla. death row inmates protest new execution drug

November 19, 2010 8:45 am | by SEAN MURPHY - Associated Press - Associated Press | Comments

Two death row inmates in Oklahoma asked a federal judge on Friday to stop their pending executions after the state said it planned to substitute the anesthetic used during lethal injections because of a drug shortage.Oklahoma is one of several states that have been scrambling after the sole...

Propoxyphene: Withdrawal - Risk of Cardiac Toxicity(2)

November 19, 2010 8:31 am | by U.S. Food & Drug Administration | Comments

New data shows that Propoxyphene and Propoxyphene-containing products can cause serious toxicity to the heart, even when used at therapeutic doses.

TOPICS:

Propoxyphene: Withdrawal - Risk of Cardiac Toxicity

November 19, 2010 8:30 am | Comments

New data shows that Propoxyphene and Propoxyphene-containing products can cause serious toxicity to the heart, even when used at therapeutic doses.

ECRI Institute PSO Chosen by Tennessee Hospital Association for Patient Safety Services

November 19, 2010 7:35 am | by Bio-Medicine.Org | Comments

PLYMOUTH MEETING, Pa., Nov. 19, 2010 /PRNewswire-USNewswire/ -- ECRI Institute Patient Safety Organization (PSO) today announces an agreement to provide patient safety services to the Tennessee Center for Patient Safety established by the Tennessee Hospital Association. ECRI Institute PSO...

TOPICS:

Boston Scientific to Acquire Sadra Medical

November 19, 2010 7:34 am | by Boston Scientific | Comments

Innovative percutaneous aortic valve replacement system provides entry into emerging market of structural heart disease

TOPICS:

Xanodyne Agrees to Withdraw Propoxyphene From the U.S. Market

November 19, 2010 7:34 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- Xanodyne Pharmaceuticals Inc., which makes Darvon and Darvocet, the brand version of the prescription pain medication propoxyphene, has agreed to withdraw the medication from the U.S. market at the request of the U.S. Food...

TOPICS:

FDA Approves Xgeva to Help Prevent Cancer-Related Bone Injury

November 19, 2010 7:34 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., Nov. 19, 2010 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading